← Back to Search

Proton Beam Therapy

Proton Therapy for Kidney Cancer

Phase < 1
Recruiting
Led By Christine Hill-Kayser, MD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The patient is a candidate for external beam radiotherapy based on standard of care for treatment of Wilms tumor or CCSK
Diagnosis of Wilms tumor or clear cell sarcoma of the kidney requiring radiation therapy as standard of care, including favorable histology (FH), stage III disease, focal or diffuse anaplasia, or CCSK
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial is testing proton therapy to treat renal tumors in the flank region to see if it is safe.

Who is the study for?
This trial is for patients under 30 years old with renal tumors, specifically Wilms tumor or clear cell sarcoma of the kidney (CCSK), who need radiation therapy as part of their standard care. It's not open to those who are pregnant, breastfeeding, have had previous radiotherapy in the cancer area, or chemotherapy for these diagnoses.Check my eligibility
What is being tested?
The study is testing how safe and tolerable proton beam radiation using pencil beam scanning is for treating renal tumors. This pilot study focuses on acute toxicity experienced by patients receiving this type of flank irradiation.See study design
What are the potential side effects?
While specific side effects aren't listed here, acute toxicity generally refers to immediate reactions from treatment such as skin irritation, fatigue, nausea or other organ-specific issues depending on the radiation target area.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am eligible for a type of radiation therapy for my Wilms tumor or CCSK.
Select...
I have been diagnosed with a specific kidney cancer that needs radiation.
Select...
I am under 30 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Occurrence of any non-hematologic toxicity that occurs within 90 days following the start of proton therapy assessed with with NCI Common toxicity criteria (CTC Version 4.0) grades].

Trial Design

1Treatment groups
Experimental Treatment
Group I: Renal tumorsExperimental Treatment1 Intervention
Any patient with Wilms tumor or clear cell sarcoma of the kidney who would require radiation therapy as standard of care. Patients may receive an investigation drug for Wilms or CCSK given concurrently or within the first four weeks of the first fraction of proton therapy administration.

Find a Location

Who is running the clinical trial?

Children's Hospital of PhiladelphiaLead Sponsor
710 Previous Clinical Trials
8,588,936 Total Patients Enrolled
Christine Hill-Kayser, MDPrincipal InvestigatorChildren's Hospital of Philadelphia
2 Previous Clinical Trials
55 Total Patients Enrolled

Media Library

Proton Beam Radiation (Proton Beam Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT03810651 — Phase < 1
Kidney Tumors Research Study Groups: Renal tumors
Kidney Tumors Clinical Trial 2023: Proton Beam Radiation Highlights & Side Effects. Trial Name: NCT03810651 — Phase < 1
Proton Beam Radiation (Proton Beam Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03810651 — Phase < 1
~4 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top